老虎证券

美股详情
本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

泰和诚医疗

4.44
-0.0600-1.33%
成交量：7,494.00
成交额：3.29万
市值：1,927.72万
市盈率：-0.37
高：4.62
开：4.59
低：4.16
收：4.50
数据加载中...
总览公司新闻公告
2024/04/19

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/08/17

SEC问询函

Form CORRESP - Correspondence
2023/07/14

SEC问询函

Form CORRESP - Correspondence
2023/04/19

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/04/29

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/08/26

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/04/30

年度报告

Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/03/11

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/02

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/29

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/26

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/04/30

年度报告

Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2019/03/19

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/19

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/01/16

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2018/12/07

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/08/30

非美公司披露报告

2018/04/04

非美公司披露报告

2017/12/21

非美公司披露报告

更多